Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Perneczky

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Journal of Neurology|October 16, 2007
Gender differences in brain reserve : an (18)F-FDG PET study in Alzheimer's diseaseR Perneczky, A Drzezga, J Diehl-Schmid, et al.
Der Nervenarzt|October 28, 2009
[Personality in old age]H Förstl, R Perneczky, A Karenberg, et al.
Fortschritte Der Neurologie-Psychiatrie|September 15, 2006
[Initial symptoms, survival and causes of death in 115 patients with frontotemporal lobar degeneration]J Diehl-Schmid, C Pohl, R Perneczky, et al.
Der Nervenarzt|October 13, 2010
[Cognitive reserve and its relevance for the prevention and diagnosis of dementia]R Perneczky, P Alexopoulos, G Schmid, et al.
International Journal of Geriatric Psychiatry|April 15, 2010
The sortilin-related receptor SORL1 and the amyloid cascade: a possible explanation for the concurrent elevation of CSF soluble APPalpha and APPbeta in Alzheimer's diseaseP Alexopoulos, A Kurz, P Lewczuk, et al.
Dementia and Geriatric Cognitive Disorders|June 25, 2005
The Alzheimer variant of lewy body disease: a pathologically confirmed case-control studyR Perneczky, D Mösch, M Neumann, et al.
Translational Psychiatry|February 21, 2013
Soluble amyloid precursor protein β as blood-based biomarker of Alzheimer's diseaseR Perneczky, L H Guo, S M Kagerbauer, et al.
Neurology|June 25, 2011
CSF soluble amyloid precursor proteins in the diagnosis of incipient Alzheimer diseaseR Perneczky, A Tsolakidou, A Arnold, et al.
Dementia and Geriatric Cognitive Disorders|September 7, 2006
Longitudinal changes of cerebral glucose metabolism in semantic dementiaJ Diehl-Schmid, T Grimmer, A Drzezga, et al.
Neurobiology of Aging|April 21, 2009
No association of Tachykinin receptor 2 (TACR2) polymorphisms with Alzheimer's diseaseP Friedrich, T M Feulner, S M Laws, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Journal of Neurology|October 16, 2007
Gender differences in brain reserve : an (18)F-FDG PET study in Alzheimer's diseaseR Perneczky, A Drzezga, J Diehl-Schmid, et al.
Der Nervenarzt|October 28, 2009
[Personality in old age]H Förstl, R Perneczky, A Karenberg, et al.
Fortschritte Der Neurologie-Psychiatrie|September 15, 2006
[Initial symptoms, survival and causes of death in 115 patients with frontotemporal lobar degeneration]J Diehl-Schmid, C Pohl, R Perneczky, et al.
Der Nervenarzt|October 13, 2010
[Cognitive reserve and its relevance for the prevention and diagnosis of dementia]R Perneczky, P Alexopoulos, G Schmid, et al.
International Journal of Geriatric Psychiatry|April 15, 2010
The sortilin-related receptor SORL1 and the amyloid cascade: a possible explanation for the concurrent elevation of CSF soluble APPalpha and APPbeta in Alzheimer's diseaseP Alexopoulos, A Kurz, P Lewczuk, et al.
Dementia and Geriatric Cognitive Disorders|June 25, 2005
The Alzheimer variant of lewy body disease: a pathologically confirmed case-control studyR Perneczky, D Mösch, M Neumann, et al.
Translational Psychiatry|February 21, 2013
Soluble amyloid precursor protein β as blood-based biomarker of Alzheimer's diseaseR Perneczky, L H Guo, S M Kagerbauer, et al.
Neurology|June 25, 2011
CSF soluble amyloid precursor proteins in the diagnosis of incipient Alzheimer diseaseR Perneczky, A Tsolakidou, A Arnold, et al.
Dementia and Geriatric Cognitive Disorders|September 7, 2006
Longitudinal changes of cerebral glucose metabolism in semantic dementiaJ Diehl-Schmid, T Grimmer, A Drzezga, et al.
Neurobiology of Aging|April 21, 2009
No association of Tachykinin receptor 2 (TACR2) polymorphisms with Alzheimer's diseaseP Friedrich, T M Feulner, S M Laws, et al.
Pageof 4